Menu Back to Regulatory-Strategy
This track explores the various aspects relating to the European Regulatory Network Strategy. It looks at novel therapies coming to the market, building further capabilities in regulatory science, ongoing developments in biosimilars, development support and the future of evidence as it relates to regulatory approvals.
Who is This Track Designed For?
Professionals involved in regulatory strategy, regulatory policy and intelligence, market access and HTA policy, project management, academics and consultants.